Vaxcyte Inc (NAS:PCVX)
$ 68.7 -0.06 (-0.09%) Market Cap: 7.47 Bil Enterprise Value: 6.02 Bil PE Ratio: 0 PB Ratio: 3.77 GF Score: 43/100

Vaxcyte Inc at Bank of America Global Healthcare Conference Transcript

May 10, 2023 / 09:20PM GMT
Release Date Price: $52.33 (-1.84%)
Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

Thank you so much for joining us at the Bank of America Annual Healthcare Conference. My name is Jason Gerberry, I'm one of the biotech analysts here. I'm pleased to be introducing our next company presenter, Vaxcyte. We've got Grant Pickering, CEO; Andrew Guggenhime, CFO; Jim Wassil, COO. So gentlemen, thanks for joining us.

Grant E. Pickering
Vaxcyte, Inc. - Co-Founder, CEO & Director

Our pleasure. Thank you for having us.

Jason Matthew Gerberry
BofA Securities, Research Division - MD in US Equity Research

So maybe I don't know if you have any brief kind of prepared remarks that you may want to offer up at all, or you just want to jump straight into Q&A.

Grant E. Pickering
Vaxcyte, Inc. - Co-Founder, CEO & Director

I'd say we just jump right into Q&A. We'll let you drive.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot